$14.0M
The Oxford medical technology company secured backing from investors including Mercia and IQ Capital to scale its diagnostic software.
O
Optellum
Optellum develops artificial intelligence software to diagnose early-stage lung cancer.
Oxford, UK—Founded 2016
$14.0MTotal raised
An Oxford-based medical technology company providing an artificial intelligence platform for the early diagnosis and management of lung cancer.
Categories
Founders
VP
Vaclav Potesil
Founder